HP

HeidelbergCapital Private Equity

Europe, Baden-Wurttemberg, Germany, Heidelberg

Description

HeidelbergCapital Private Equity is an independent investment company.

Investor Profile

HeidelbergCapital Private Equity has backed more than 4 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 50% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Private Equity, Series C, Series G rounds (top funding stages).
  • Majority of deals are located in Germany, Singapore.
  • Strong thematic focus on Biotechnology, Medical, Therapeutics.

Stage Focus

  • Private Equity (25%)
  • Series C (25%)
  • Series G (25%)
  • Series Unknown (25%)

Country Focus

  • Germany (75%)
  • Singapore (25%)

Industry Focus

  • Biotechnology
  • Medical
  • Therapeutics
  • Pharmaceutical
  • Cloud Management
  • E-commerce
  • Software
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HeidelbergCapital Private Equity frequently co-invest with?

Co-Investments: 1
VI Partners
Europe, Schwyz, Switzerland, Altendorf
Co-Investments: 1
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Co-Investments: 1
Future Capital Development Fund
North America, Virginia, United States, Richmond
Co-Investments: 1
Rosetta Capital
Europe, England, United Kingdom, London
Co-Investments: 1
HA
Europe, England, United Kingdom, London
Co-Investments: 2
Aurelia Private Equity
Europe, Hessen, Germany, Frankfurt
Co-Investments: 1
EDBI
Asia, Central Region, Singapore, Singapore
Co-Investments: 1
Bayern Kapital
Europe, Bayern, Germany, Landshut
Co-Investments: 2

What are some of recent deals done by HeidelbergCapital Private Equity?

Vasopharm

Würzburg, Bayern, Germany

Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.

BiotechnologyMedicalTherapeutics
Private EquityJul 11, 2019
Amount Raised: $10,687,306
Vasopharm

Würzburg, Bayern, Germany

Vasopharm is focused on the R&D of novel therapeutics for the treatment of cerebro and cardiovascular diseases and their symptoms.

BiotechnologyMedicalTherapeutics
Series GJan 21, 2016
Amount Raised: $21,737,500
Onventis

Stuttgart, Baden-Wurttemberg, Germany

Onventis is a leading supplier of Cloud Procurement and SRM.

Cloud ManagementE-CommerceSoftware
Series UnknownJun 11, 2015
MerLion Pharma

Singapore, Central Region, Singapore

MerLion Pharmaceuticals is a drug discovery and development company that researches and develops natural products.

BiotechnologyPharmaceutical
Series COct 11, 2010
Amount Raised: $7,000,000

Find More Investors Like HeidelbergCapital Private Equity

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides

HeidelbergCapital Private Equity | Pipeseed